BSE filing, NSE: SYMBIOTEC. Summary written from the filing by ALFA Finder's alert engine.
Symbiotec Pharmalab Ltd: key numbers
- Share price
- ₹1,246.30
- Market cap
- ₹8,008 Cr
- Revenue (annual)
- ₹869.1 Cr
- Net profit (annual)
- ₹109.9 Cr
- Promoter holding
- 33.28%
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Symbiotec Pharmalab Ltd
All →Symbiotec Pharmalab Board Meeting Date
Symbiotec Pharmalab schedules a 5 November 2026 board meeting to consider unaudited quarterly and half-year results. No amounts are proposed.
Symbiotec Pharmalab Share Pledge
Promoters of Symbiotec Pharmalab submitted a revised disclosure to update the lender and trustee names for their pledged share encumbrance.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of the SEBI LODR Regulations.
Symbiotec Pharmalab Other Announcement
Symbiotec Pharmalab has filed the routine quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ending September 30, 2026.
Symbiotec Pharmalab Other Announcement
Designated persons of Symbiotec Pharmalab sold equity shares worth ₹11.94 crore in the open market. This disclosure complies with PIT Regulation 7(2).
- Value
- ₹11.94 Cr
Symbiotec Pharmalab Business Update
Symbiotec Pharmalab received an Establishment Inspection Report (EIR) from the U.S. FDA for its Pithampur manufacturing facility. The inspection concluded with a Voluntary Action Indicated (VAI) classification.
- From
- U.S. Food and Drug Administration (U.S. FDA)
Other capital structure change announcements
All →LG Balakrishnan & Bros Capital Structure Change
LG Balakrishnan & Bros will invest Rs 9.79 Crore in its subsidiary SLGB Energy Solutions via rights subscription. The funds support commencement of commercial operations.
- Value
- ₹9.79 Cr
LG Balakrishnan & Bros Capital Structure Change
LG Balakrishnan & Bros will invest Rs 15.01 Crore via rights subscription in its wholly owned subsidiary. The investment supports expansion of the subsidiary's business.
- Value
- ₹15.01 Cr
Dhoot Transmission Capital Structure Change
Dhoot Transmission bought 2,50,000 shares in its German subsidiary for cash of Rs.2.82 Crore. The filing says the capital will fund working capital and growth.
- Value
- ₹2.82 Cr
Dhoot Transmission Capital Structure Change
Dhoot Transmission invested €2.5 lakh in its wholly-owned German subsidiary, about ₹2.65 Crore. The stake stays at 100%, so control is unchanged.
- Value
- ₹2.65 Cr
New Light Industries Capital Structure Change
Amit HUF and PACs bought 27,52,000 New Light Industries shares via market purchase, lifting their combined stake from 2.63% to 5.77%. The disclosure is a non-promoter SAST Regulation 29(1) filing.
Ramkrishna Forgings Capital Structure Change
Ramkrishna Forgings will invest Rs.56.76 Crore in subsidiary Ramkrishna Titagarh Rail Wheels via equity, in tranches. Funds support the Chennai forged-wheel plant; holding stays at 51%.
- Value
- ₹56.76 Cr